Latest period
$484M
YoY change
-6.8%
5Y CAGR
+8.4%
Peak year (FY2024)
$530M
Latest annual
$494M
Stock-Based Compensation history chart for Amgen (AMGN) from 2016 to 2025
Latest: $494M
Stock-Based Compensation growth chart for Amgen (AMGN) from 2016 to 2025
Latest: -6.8%
Stock-Based Compensation history table for Amgen (AMGN) from 1988 to 2025
| FY2025 | $494M | -6.8% | -$36M | ||
| FY2024 | $530M | +23.0% | +$99M | ||
| FY2023 | $431M | +7.5% | +$30M | ||
| FY2022 | $401M | +17.6% | +$60M | ||
| FY2021 | $341M | +3.3% | +$11M | ||
| FY2020 | $330M | +7.1% | +$22M | ||
| FY2019 | $308M | -1.0% | -$3M | ||
| FY2018 | $311M | -5.5% | -$18M | ||
| FY2017 | $329M | +5.8% | +$18M | ||
| FY2016 | $311M | -3.4% | -$11M | ||
| FY2015 | $322M | -21.1% | -$86M | ||
| FY2014 | $408M | +1.2% | +$5M | ||
| FY2013 | $403M | +11.3% | +$41M | ||
| FY2012 | $362M | +6.2% | +$21M | ||
| FY2011 | $341M | -3.4% | -$12M | ||
| FY2010 | $353M | +24.3% | +$69M | ||
| FY2009 | $284M | — | +$284M | ||
| FY2008 | $0.00 | — | $0.00 | ||
| FY2007 | $0.00 | — | $0.00 | ||
| FY2006 | $0.00 | — | $0.00 | ||
| FY2005 | $0.00 | — | $0.00 | ||
| FY2004 | $0.00 | — | $0.00 | ||
| FY2003 | $0.00 | — | $0.00 | ||
| FY2002 | $0.00 | — | $0.00 | ||
| FY2001 | $0.00 | — | $0.00 | ||
| FY2000 | $0.00 | — | $0.00 | ||
| FY1999 | $0.00 | — | $0.00 | ||
| FY1998 | $0.00 | — | $0.00 | ||
| FY1997 | $0.00 | — | $0.00 | ||
| FY1996 | $0.00 | — | $0.00 | ||
| FY1995 | $0.00 | — | $0.00 | ||
| FY1994 | $0.00 | — | $0.00 | ||
| FY1993 | $0.00 | — | $0.00 | ||
| FY1992 | $0.00 | — | $0.00 | ||
| FY1991 | $0.00 | — | $0.00 | ||
| FY1990 | $0.00 | — | $0.00 | ||
| FY1989 | $0.00 | — | $0.00 | ||
| FY1988 | $0.00 | — | — |
- FY2025$494M-6.8%
- FY2024$530M+23.0%
- FY2023$431M+7.5%
- FY2022$401M+17.6%
- FY2021$341M+3.3%
- FY2020$330M+7.1%
- FY2019$308M-1.0%
- FY2018$311M-5.5%
- FY2017$329M+5.8%
- FY2016$311M-3.4%
- FY2015$322M-21.1%
- FY2014$408M+1.2%
- FY2013$403M+11.3%
- FY2012$362M+6.2%
- FY2011$341M-3.4%
- FY2010$353M+24.3%
- FY2009$284M—
- FY2008$0.00—
- FY2007$0.00—
- FY2006$0.00—
- FY2005$0.00—
- FY2004$0.00—
- FY2003$0.00—
- FY2002$0.00—
- FY2001$0.00—
- FY2000$0.00—
- FY1999$0.00—
- FY1998$0.00—
- FY1997$0.00—
- FY1996$0.00—
- FY1995$0.00—
- FY1994$0.00—
- FY1993$0.00—
- FY1992$0.00—
- FY1991$0.00—
- FY1990$0.00—
- FY1989$0.00—
- FY1988$0.00—
Stock-Based Compensation values are taken from Amgen's reported cash flow statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Stock-Based Compensation at Amgen (AMGN)
Stock-Based Compensation for Amgen (AMGN): headline value $484M · YoY -6.8%. Annual and quarterly series, chart, and tables are below.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
The 2025 reading of Amgen (AMGN) stock-based compensation is $494M – declined 6.8% year-over-year.
Looking at the 2020–2025 (5 years) stretch, Amgen stock-based compensation compounded at +8.4% per year, with mixed annual results across the window.
The highest annual stock-based compensation of $530M was reported in 2024. The lowest in the available history was $0.00 in 1988.
Amgen Stock-Based Compensation by Year
Amgen Stock-Based Compensation 2025: $494M
Amgen stock-based compensation in 2025 was $494M, declined 6.8% below 2024.
Amgen Stock-Based Compensation 2024: $530M
2024's stock-based compensation for Amgen came in at $530M, grew 23.0% from 2023. This figure represents the highest annual value in the available history.
Amgen Stock-Based Compensation 2023: $431M
Amgen posted stock-based compensation of $431M in 2023, grew 7.5% from 2022.
Amgen Stock-Based Compensation 2022: $401M
In 2022, Amgen reported stock-based compensation of $401M, grew 17.6% from 2021.
Amgen Stock-Based Compensation 2021: $341M
Amgen stock-based compensation in 2021 was $341M.
See more financial history for Amgen (AMGN).
Sector peers by Stock-Based Compensation
Healthcare peers of Amgen (AMGN), ranked by their latest stock-based compensation
Frequently asked questions
Amgen (AMGN) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation
- Buybacks
- Dividend Profile2.54% yield
- Dividend Calculator
- Dividend Forecast
- Dividend Capture
- Stock Split History5 splits
How this company returns cash to shareholders — buybacks, dividends, and stock splits.